Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic
Coventry Celebrates the Power, Flexibility, and Value of Life Insurance During Life Insurance Awareness Month
FORT WASHINGTON, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance, is proud to recognize Life Insurance Awareness Month by
Coventry Celebrates the Power, Flexibility, and Value of Life Insurance During Life Insurance Awareness Month
FORT WASHINGTON, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance, is proud to recognize Life Insurance Awareness Month by
Axi Announces Retirement of Chief Commercial Officer Louis Cooper
Louis Cooper Chief Commercial Officer Axi ( CCO) Louis Cooper Chief Commercial Officer Axi ( CCO) SYDNEY, Sept. 22, 2025 (GLOBE NEWSWIRE) — Axi, a leading global online trading and
OPEC Fund mobilizes over US$1 billion to advance sustainable development
Governing Board approves major financing package as institution launches inaugural Euro benchmark bond OPEC Fund President Abdulhamid Alkhalifa OPEC Fund President Abdulhamid Alkhalifa VIENNA, Sept. 22, 2025 (GLOBE NEWSWIRE) —